Valeant Pharmaceuticals International - Obagi Medical Products Unit's Unit Acquisition

Valeant Pharmaceuticals International - Obagi Medical Products Unit raised a round of funding on November 10, 2017. Investors include Obagi Medical Products.

Valeant Pharmaceuticals International (NYSE/VRXTSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products primarily…

Articles about Valeant Pharmaceuticals International - Obagi Medical Products Unit's Unit Acquisition: